A case study Role of langhan and ruksha waluka sweda in aamvata
Article pdf download
Publication Certificate

Keywords

Aamvata, Langhan, Ruksha waluka sweda, Ayurved.

How to Cite

Umakant Kadam, Dr. Rajan Kulkarni, Dr. Rajan Kulkarni, Dr. Eknath kulkarni, & Dr. Sanjivani Rathod. (2020). A case study Role of langhan and ruksha waluka sweda in aamvata. Ayurline: International Journal of Research in Indian Medicine, 4(03). Retrieved from http://ayurline.in/index.php/ayurline/article/view/386

Abstract

Aamvata (RA) is a major musculoskeletal joint disease described in Ayurveda. Swelling, pain, and stiffness in the ankle, knee, hip joints, wrist, elbow, and shoulder are the clinical manifestations of Aamvata. The peak incidence of onset of RA is in persons 30 to 60 years old, but no age is immune. In the present era Aamvata is the most common disease affecting a large aged population. Aamvata term derived from words as “Aam” & “Vata”. The word Aam is the condition in which various ailments in system creates toxic effect.
The Aam when combines with Vatadosha & occupies shleshmasthana (Asthisandhi) results in painful disease “Aamvata”. According to Yogaratnakara, treatment of Aamvata should be started with Langhana (fasting) followed by Dipana (improving appetite), Pachana (improving digestion), Swedana (fomentation therapy), Virechana (Purgation) and Basti (medicated enema) sequentially.
Aamvata is one of the challenging disease for the clinicians due to its chronicity, incurability, complications and morbidity. The allopathic treatment provides the symptomatic relief but the underlined pathology remain untreated due to absence of effective therapy and also giving rise to many side effects, toxic symptoms and adverse reactions also more serious complications like organic lesions. Here we done a study on a patient of Aamavata in the management with the Langhan and Ruksha waluka sweda.

Article pdf download
Publication Certificate
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Downloads

Download data is not yet available.